PATHOLOGICAL CLASSIFICATION OF SOFT-TISSUE SARCOMAS

被引：9

作者：

FRABLE, WJ

机构：

[1] Department of Pathology, Division of Surgical Cytopathology, Virginia Commonwealth University, Health Sciences Division, Medical College of Virginia, Richmond, Virginia

来源：

SEMINARS IN SURGICAL ONCOLOGY | 1994年 / 10卷 / 05期

关键词：

VIMENTIN; MUSCLE SPECIFIC ACTIN; DESMIN; MYOGLOBIN; FACTOR-VIII; ULEX-EUROPAEUS-1; S-100; PROTEIN; CYTOKERATINS; HISTIOCYTIC MARKERS; MIC2; KI-67; P53; ELECTRON MICROSCOPY;

D O I：

10.1002/ssu.2980100505

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A number of immunological markers and chromosomal abnormalities are described to aid in the diagnosis, prognosis and management of soft tissue sarcomas. Although the chromosomal abnormalities may be specific in some cases, they have only been reported in small series or single cases and their significance has not yet been established. None of the immunological markers described is either entirely specific or sensitive for a particular tumor type, and virtually none of these immunological reagents is currently approved for diagnostic use despite their widespread applications in pathology. They function in a supporting role to conventional tissue pathology, grading, and pathological and clinical staging of soft tissue sarcomas. Antibodies employed as an aid in diagnosis of soft tissue tumors should always be run in panels and never as single tests. New immunological markers and chromosomal abnormalities in soft tissue sarcomas should be carefully evaluated for their specificity and sensitivity and their usefulness in diagnosis and prognosis. (C) 1994 Wiley-Liss, Inc.

引用

页码：332 / 339

页数：8

共 103 条

[31]

Barbareschi M, Mauri MF, Muscara M, Et al., S‐100 protein in human lung neuroendocrine neoplasms. Immunohistochemical study of 14 cases and review of the literature, Histol Histopathol, 2, pp. 185-192, (1987)

[32]

Barwick KW, S‐100 protein, Atlas of Diagnostic Immunohistopathology, pp. 2-20, (1990)

[33]

Ordonez NG, Mahfouz SM, Mackay B, Synovial sarcoma: An immunohistochemical study, Hum Pathol, 21, pp. 733-749, (1990)

[34]

Wrba F, Fertl H, Amann G, Et al., Epithelial markers in synovial sarcoma. An immunohistochemical study on paraffin embedded tissue, Virchows Arch A Pathol Anat Histopathol, 415, pp. 253-258, (1989)

[35]

Otto HF, Schweckheimer BK, Moller P, Et al., Mesenchymal tumor markers: Special proteins and enzymes, Curr Top Pathol, 77, pp. 179-205, (1987)

[36]

Ambros IM, Ambros PF, Strehl S, Et al., MIC2 is a specific marker for Ewing's sarcoma ad peripheral primitive neuroectodermal tumors, Cancer, 67, pp. 1893-1991, (1991)

[37]

Goodfellow P, Banting G, Sheet D, Et al., Genetic evidence that a Y‐linker gene in man is homologous to a gene on the X chromosome, Nature, 302, pp. 346-349, (1983)

[38]

Weidner N, Tjoe J, Immunohistochemical profile of monoclonal antibody 013: Antibody that recognizes glycoprotein p30/32 MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma, Am J Surg Pathol, 18, pp. 486-494, (1994)

[39]

Gerdes J, Li L, Schlueter C, Et al., Immunobiochemical and molecular biologic characterization of the cell proliferation associated nuclear antigen that is defined by monoclonal antibody Ki‐67, Am J Pathol, 138, pp. 867-873, (1991)

[40]

Grogan TM, Lippman SM, Spier CM, Et al., Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki‐67, Blood, 71, pp. 1157-1160, (1988)

← 1 2 3 4 5 6 7 8 9 10 →